Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma.

Clinical and molecular hepatology

Volumn 18, Issue 3, 2012, Pages 302-308

  Lee, Hyun Seok ^a   Park, Soo Young ^b   Kim, Sung Kook ^b   Kweon, Young Oh ^b   Tak, Won Young ^b   Cho, Chang Min ^b   Jeon, Seong Woo ^b   Jung, Min Kyu ^b   Park, Hyun Gu ^b   Lee, Dong Wook ^b   Choi, So Young ^b  

^a Kyungpook National University Hospital   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BLOOD; CATHETER ABLATION; DOWN REGULATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DOWN-REGULATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

EID: 84875079760     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2012.18.3.302     Document Type: Article

References (0)